203 related articles for article (PubMed ID: 7518579)
21. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
Witthuhn BA; Williams MD; Kerawalla H; Uckun FM
Leuk Lymphoma; 1999 Jan; 32(3-4):289-97. PubMed ID: 10037026
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning of a carp Jak3 from activated leukocytes.
Yin Z; Kwang J
Vet Immunol Immunopathol; 2000 May; 74(3-4):225-36. PubMed ID: 10802290
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary analysis for functional divergence of Jak protein kinase domains and tissue-specific genes.
Gu J; Wang Y; Gu X
J Mol Evol; 2002 Jun; 54(6):725-33. PubMed ID: 12029354
[TBL] [Abstract][Full Text] [Related]
25. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
Ihle JN
Semin Immunol; 1995 Aug; 7(4):247-54. PubMed ID: 8520029
[TBL] [Abstract][Full Text] [Related]
26. Cross-regulation of JAK and Src kinases.
Ingley E; Klinken SP
Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
[TBL] [Abstract][Full Text] [Related]
27. JAK3: expression and mapping to chromosome 19p12-13.1.
Safford MG; Levenstein M; Tsifrina E; Amin S; Hawkins AL; Griffin CA; Civin CI; Small D
Exp Hematol; 1997 May; 25(5):374-86. PubMed ID: 9168059
[TBL] [Abstract][Full Text] [Related]
28. A functional Jak2 tyrosine kinase domain is essential for mouse development.
Frenzel K; Wallace TA; McDoom I; Xiao HD; Capecchi MR; Bernstein KE; Sayeski PP
Exp Cell Res; 2006 Sep; 312(15):2735-44. PubMed ID: 16887119
[TBL] [Abstract][Full Text] [Related]
29. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.
Kawahara A; Minami Y; Miyazaki T; Ihle JN; Taniguchi T
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8724-8. PubMed ID: 7568005
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of novel CIS family genes.
Masuhara M; Sakamoto H; Matsumoto A; Suzuki R; Yasukawa H; Mitsui K; Wakioka T; Tanimura S; Sasaki A; Misawa H; Yokouchi M; Ohtsubo M; Yoshimura A
Biochem Biophys Res Commun; 1997 Oct; 239(2):439-46. PubMed ID: 9344848
[TBL] [Abstract][Full Text] [Related]
31. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
32. The Janus kinases (Jaks).
Yamaoka K; Saharinen P; Pesu M; Holt VE; Silvennoinen O; O'Shea JJ
Genome Biol; 2004; 5(12):253. PubMed ID: 15575979
[TBL] [Abstract][Full Text] [Related]
33. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
Gurniak CB; Thomis DC; Berg LJ
DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
[TBL] [Abstract][Full Text] [Related]
35. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
36. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.
Silvennoinen O; Witthuhn BA; Quelle FW; Cleveland JL; Yi T; Ihle JN
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8429-33. PubMed ID: 8378315
[TBL] [Abstract][Full Text] [Related]
37. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning of a chicken JAK homolog from activated T cells.
Sofer L; Kampa D; Burnside J
Gene; 1998 Jul; 215(1):29-36. PubMed ID: 9666067
[TBL] [Abstract][Full Text] [Related]
39. Critical sites for the interaction between IL-2Rgamma and JAK3 and the following signaling.
Tang W; Huo H; Zhu J; Ji H; Zou W; Xu L; Sun L; Zheng Z; Theze J; Liu X
Biochem Biophys Res Commun; 2001 May; 283(3):598-605. PubMed ID: 11341766
[TBL] [Abstract][Full Text] [Related]
40. Cloning and characterization of the human homolog of mouse Jak2.
Dalal I; Arpaia E; Dadi H; Kulkarni S; Squire J; Roifman CM
Blood; 1998 Feb; 91(3):844-51. PubMed ID: 9446644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
